AVPR1A and schizophrenia: These results allow a conclusion to be drawn that changes in the expression of the major cerebral vasopressin receptor, i.e., AVPR1a, may play a role in the pathogenesis of schizophrenia, especially in the development of cognitive deficits that also increase with the duration of the illness [28].